Why Is PLx Pharma (PLXP) Stock Down 32% Today?
Why Is PLx Pharma (PLXP) Stock Down 38% Today?
Spotting Winning Penny Stocks: 3 Top Tips
PLx Pharma (PLXP) Q3 2022 Earnings Call Transcript
PLx Pharma, Inc. (PLXP) Reports Q3 Loss, Misses Revenue Estimates
PLx Pharma Inc. to Report Third Quarter 2022 Financial Results on November 11, 2022, and Provide Business Update
PLx Pharma Inc. (PLXP) CEO, Natasha Giordano on Q2 2022 Results - Earnings Call Transcript
PLx Pharma, Inc. (PLXP) Reports Q2 Loss, Lags Revenue Estimates
PLx Pharma (PLXP) CEO, Natasha Giordano on Q1 2022 Results - Earnings Call Transcript
PLx Pharma, Inc. (PLXP) Reports Q1 Loss, Lags Revenue Estimates
PLx Pharma Inc. to Discuss 2022 First Quarter Financial Results on May 13, 2022 Conference Call and Provide Business Update
PLx Pharma Inc. (PLXP) CEO Natasha Giordano on Q4 2021 Results - Earnings Call Transcript
Dipexium Pharmaceuticals, Inc. (PLXP) Reports Q4 Loss, Misses Revenue Estimates
PLx Pharma Inc. to Present at Oppenheimer & Co's 32nd Annual Healthcare Conference on March 15, 2022
PLx Pharma Inc. to Discuss 2021 Fourth Quarter Financial Results on March 11, 2022 Conference Call and Provide Business Update
Implied Volatility Surging for Dipexium Pharmaceuticals (PLXP) Stock Options
PLx Pharma Inc. to Present at Piper Sandler 33rd Annual Healthcare Conference 2021
PLx Pharma Inc. (PLXP) CEO Natasha Giordano on Q3 2021 Results - Earnings Call Transcript
PLx Pharma Inc. to Discuss 2021 Third Quarter Financial Results on November 12, 2021 Conference Call and Provide Business Update
PLx Pharma stock drops again, and company looks to clarify USPTF's recent comments about aspirin use
PLx Pharma: First Commercial Launch Makes It Attractive
PLx Pharma Inc. to Present at Upcoming Virtual Healthcare Industry Conferences
PLx Pharma Inc.'s VAZALORE™ Now on Shelves; National Media Campaign Launches Today
PLx Pharma's (PLXP) CEO Natasha Giordano on Q2 2021 Results - Earnings Call Transcript
PLx Pharma Inc. Reports Second Quarter 2021 Results and Provides Business Update
PLx Pharma Inc.'s VAZALORE to Launch in Nearly 8,000 CVS Stores this Month
PLx Pharma Inc.'s VAZALORE to Launch in Over 2,400 Rite Aid Stores in August
PLx Pharma Inc. to Discuss 2021 Second Quarter Financial Results on August 6, 2021 Conference Call and Provide Business Update
Why PLx Pharma Blasted Nearly 20% Higher Today
PLXP Stock Increases Over 10% Pre-Market: Why It Happened
PLx Pharma Inc.'s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwide in August
Why PLx Pharma Took Off Like a Rocket Today
PLXP Stock Increases Over 20% Pre-Market: Why It Happened
PLx Pharma Inc.'s VAZALORE to Launch in over 4,500 Walmart Stores Nationwide in August
PLx Pharma Inc. to Present at Upcoming Healthcare Industry Conferences
PLx Pharma Inc. (PLXP) CEO Natasha Giordano on Q1 2021 Results - Earnings Call Transcript
PLx Pharma Inc. Reports First Quarter 2021 Results and Provides Business Update
Is a Surprise Coming for PLx Pharma (PLXP) This Earnings Season?
PLx Pharma Inc. to Discuss 2021 First Quarter Financial Results on May 14, 2021 Conference Call and Provide Business Update
New Analyst Coverage Puts Spotlight on These 4 Stocks
PLx Pharma Inc. Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
PLx Pharma Inc. to Present at the Oppenheimer 31st Annual Healthcare Conference
PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update
PLx Pharma Inc. Prices $63 Million Underwritten Public Offering of Common Stock
PLx Pharma Inc. Announces Proposed Public Offering of Common Stock
PLx Pharma Receives FDA Approval of SNDAs for Both VAZALORE 325 mg and 81 mg
Is PLx Pharma Inc. (PLXP) A Good Stock To Buy?
PLx Pharma Inc. (PLXP) CEO Natasha Giordano on Q3 2020 Results - Earnings Call Transcript
PLx Pharma Inc. Reports Third Quarter 2020 Results and Provides Business Update
PLx Pharma Inc. Submits Supplemental New Drug Applications for VAZALORE™ 325 mg and 81 mg to U.S. Food and Drug Administration